Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleDiabetes once-weekly drug.AuthorsSinha, GunjanAbstractThe article reports on the launching by Amylin of its Bydureon (exenatide) type 2 diabetes in the U.S. market in February 2012 following the approval by the Food and Drug Administration.SubjectsUNITED States; BYDUREON (Company); TYPE 2 diabetesPublicationNature Biotechnology, 2012, Vol 30, Issue 3, p201ISSN1087-0156Publication typeArticleDOI10.1038/nbt0312-201b